These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10229954)

  • 1. [In children with refractory epilepsy: vigabatrin or lamotrigine?].
    Caviedes BE; Herranz JL; Arteaga R; Armijo JA
    Rev Neurol; 1999 Mar 1-15; 28(5):444-8. PubMed ID: 10229954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes.
    Bélanger S; Coulombe G; Carmant L
    Epilepsia; 1998 Aug; 39(8):878-83. PubMed ID: 9701380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of lamotrigine and vigabatrin in drug-resistant epilepsies of childhood.
    Dimova PS; Korinthenberg R
    Pediatr Neurol; 1999 Nov; 21(5):802-7. PubMed ID: 10593670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vigabatrin and lamotrigine in refractory epilepsy.
    Stolarek I; Blacklaw J; Forrest G; Brodie MJ
    J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):921-4. PubMed ID: 8057114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lamotrigine versus vigabatrin as an add-on therapy in refractory epilepsy: prospective study].
    Maciejek Z; Niezgodzińska-Maciejek A
    Neurol Neurochir Pol; 2000; 34 Suppl 1():165-75. PubMed ID: 10768156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of refractory infantile epilepsy with vigabatrin in a series of 55 patients].
    López-Valdés E; Hernández-Laín A; Simón R; Porta J; Mateos F
    Rev Neurol; 1996 Oct; 24(134):1255-7. PubMed ID: 8983724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new antiepileptic drugs: a systematic review of their efficacy and tolerability.
    Marson AG; Kadir ZA; Hutton JL; Chadwick DW
    Epilepsia; 1997 Aug; 38(8):859-80. PubMed ID: 9579887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey comparing lamotrigine and vigabatrin in everyday clinical practice.
    Schapel G; Chadwick D
    Seizure; 1996 Dec; 5(4):267-70. PubMed ID: 8952011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination vigabatrin and lamotrigine therapy for intractable epilepsy.
    Schapel GJ; Black AB; Lam EL; Robinson M; Dollman WB
    Seizure; 1996 Mar; 5(1):51-6. PubMed ID: 8777553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding antiepileptic drug options: clinical efficacy of new therapeutic agents.
    Ben-Menachem E
    Epilepsia; 1996; 37 Suppl 2():S4-S7. PubMed ID: 8641244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long-term use of vigabatrin and lamotrigine in patients with severe childhood onset epilepsy.
    Kluger G; Berz K; Holthausen H
    Eur J Paediatr Neurol; 2001; 5(1):37-40. PubMed ID: 11277363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigabatrin serum concentration to dosage ratio: influence of age and associated antiepileptic drugs.
    Armijo JA; Cuadrado A; Bravo J; Arteaga R
    Ther Drug Monit; 1997 Oct; 19(5):491-8. PubMed ID: 9357089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of lamotrigine and vigabatrin treatment in children with severe epilepsy.
    Schapel GJ; Wallace SJ; Gordon GS
    Seizure; 1997 Dec; 6(6):479-83. PubMed ID: 9530945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term use of gabapentin, lamotrigine, and vigabatrin in patients with chronic epilepsy.
    Wong IC; Chadwick DW; Fenwick PB; Mawer GE; Sander JW
    Epilepsia; 1999 Oct; 40(10):1439-45. PubMed ID: 10528941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vigabatrin withdrawal randomized study in children.
    Chiron C; Dulac O; Gram L
    Epilepsy Res; 1996 Nov; 25(3):209-15. PubMed ID: 8956918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Vigabatrin and lamotrigin: experiences with 2 new anticonvulsants in the Swiss epilepsy clinic].
    Vogt H; Krämer G
    Schweiz Med Wochenschr; 1995 Jan; 125(4):125-32. PubMed ID: 7878401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vigabatrin: results with a new antiepileptic agents in 57 patients in a general neurological practice].
    van der Zwan A; van der Zwan A
    Ned Tijdschr Geneeskd; 1994 Sep; 138(37):1859-63. PubMed ID: 7935922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile.
    Camposano SE; Major P; Halpern E; Thiele EA
    Epilepsia; 2008 Jul; 49(7):1186-91. PubMed ID: 18479386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study.
    Eriksson AS; Nergårdh A; Hoppu K
    Epilepsia; 1998 May; 39(5):495-501. PubMed ID: 9596201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.